Clinical Trials
61 trialsHISMAR
Hôpital du Valais
GALILEE
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Memorial Sloan Kettering Cancer Center
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Methodist Health System
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Blue Earth Diagnostics
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
University of California, Davis
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
University of California, San Francisco
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Memorial Sloan Kettering Cancer Center
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Alliance for Clinical Trials in Oncology
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
LBC-Monitor
University of Pittsburgh
FAPI-CL
Hospices Civils de Lyon
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
M.D. Anderson Cancer Center
CDH1 Germline Mutations in Lobular Breast Cancer
European Institute of Oncology
LobularCard
European Institute of Oncology
ROLo
Royal Marsden NHS Foundation Trust
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
City of Hope Medical Center
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Vanderbilt-Ingram Cancer Center
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
City of Hope Medical Center
CAREFOR
Thomas Jefferson University
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
University of Utah
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Dana-Farber Cancer Institute
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Emory University
FESTA
Università Vita-Salute San Raffaele
ROSALINE
Jules Bordet Institute
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma
Asan Medical Center
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
University of Chicago
Radiation Therapy in Treating Women With Early Stage Breast Cancer
Rutgers, The State University of New Jersey
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Rutgers, The State University of New Jersey
MINDACT
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Single Fraction Intraoperative Radiotherapy
St. Joseph Hospital of Orange
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Living Well After Breast Surgery
University of Texas at Austin
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Memorial Sloan Kettering Cancer Center
ICG
Abramson Cancer Center at Penn Medicine
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer
Abramson Cancer Center at Penn Medicine
Broccoli Sprout Extract in Treating Patients With Breast Cancer
Roswell Park Cancer Institute
ACRIN-6667
American College of Radiology Imaging Network
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
Sunnybrook Health Sciences Centre
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
University of Alabama at Birmingham
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
University of California, Davis
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
City of Hope Medical Center
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Radiation Therapy in Treating Women With Invasive Breast Cancer
University of California, San Francisco